Corporate Banner
Satellite Banner
Technology Networks Header
Friday, November 28, 2014
 
Register | Sign in
Home Page>Products
  Product News
New Application Note from Malvern Instruments
Thursday, November 27, 2014
Application note shows value of Nanoparticle Tracking Analysis in exosome studies.

Morphologi G3-ID Accelerates Environmental Particle Research At Southern Cross University, Australia
Thursday, November 27, 2014
The Morphologi G3-ID is helping users understand the composition and behavior of natural particles within the environment.

Quick and Easy Determination of Trace Sodium in Diesel Fuels
Wednesday, November 26, 2014
An automated in-line matrix elimination technique that simplifies the determination of trace sodium.

Quick Evaluation with New UNICORN™ 7.0 Software
Wednesday, November 26, 2014
The software controls protein purification runs as well as cell culture and preparation.

Studying Plant Cells Using AFM and the CellHesion® Module
Tuesday, November 25, 2014
JPK reports on the use of AFM and the CellHesion® module to study plant cells at the University of Queensland.

25 Years of Revolutionary Microplate Reader Technology at SLAS 2015
Tuesday, November 25, 2014
BMG LABTECH will showcase what is new with microplate reader technology.

Imaging Cancer Growth
Tuesday, November 25, 2014
LaVision BioTec reports on the award-winning scientist Peter Friedl and his work imaging cancer growth.

Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.

Specialist Analytical Services for the Construction Industry
Tuesday, November 25, 2014
Warwick Analytical Service (WAS) reports on specialist analytical services it has been providing to Normet (UK) Ltd.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10687
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv